Key result
Calmodulin acts as a state-dependent switch to control cardiac potassium channel KCNQ1 opening and voltage-dependent activation.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Does not alter arrhythmia management; leaves open calmodulin-KCNQ1 targeting for future therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2020) studied this question. Calmodulin acts as a state-dependent switch to control cardiac potassium channel KCNQ1 opening and voltage-dependent activation.
Synapse has enriched 10 related papers. Consider them for comparative context: